Study drug levels in epilepsy meds during pregnancy and breastfeeding
Treatments studied
Part of Brain & nervous system clinical trials.
This study measures how much epilepsy medicine (lamotrigine, levetiracetam, or oxcarbazepine) your body absorbs during pregnancy and breastfeeding. It may help doctors better understand dosing and safety during these times.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman ages 18–45 with epilepsy and you are planning pregnancy or in early pregnancy
- You take lamotrigine, levetiracetam, or oxcarbazepine as your epilepsy medicine
- You can keep a daily diary of your medicine and seizures (or symptoms)
- You can complete questionnaires about side effects
- You have not had “functional seizures” (also called non-epileptic seizures)
- You do not have serious kidney or liver problems, major progressive brain conditions, or recent drug/alcohol misuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how epilepsy and epilepsy medications affect bone health during pregnancy and after delivery. Researchers want to understand how to keep bones strong while you're pregnant and taking seizure medications, which can sometimes weaken bones.
This trial studies whether adding a medicine called lamotrigine to valproate reduces seizures in children who haven’t fully stopped having seizures yet. It will also watch safety with lab tests and the child’s overall response.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This study looks at what happens when people with epilepsy stop their seizure medications. The goal is to see if it's safe to stop after being seizure-free for a while, and to help patients and doctors make better decisions.
This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.
This trial tests whether a guided music program (called “The Lullaby Project”) can be helpful during pregnancy for people with epilepsy. It focuses on participating in online musical sessions while you’re pregnant.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.